ArticleScientific reports2024

NMR-based metabolomics identification of potential serum biomarkers of disease progression in patients with multiple sclerosis.

Mohammad Alwahsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.